Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 2142142 | OT |
no adverse event; temperature excursion; This spontaneous invalid report was received from a/an Consumer or other non health professional and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 04-Sep-2025, the patient started therapy with Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), (lot #2142142, expiration date: 09-Jun-2026) administered by Oral route. On 04-Sep-2025, the patient experienced temperature excursion (temperature: 67.8 F ; Time frame: 48 hours 56 minutes). There was no previous temperature excursion. No adverse event was reported. This is an invalid report due to lack of patient's identifiers.